You make a good case for an exception and/or appeal. Perhpas if your plan cannot deliver a U200 rapid acting analog alternative and your current care is based on a U200 concentration, maybe the plan would let you stick with the Humalog. They should. They are not providing an equivalent therapy.
I did a quick search and the only other U200 insulins are in the longer acting variety like Tresiba U200.